BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $23.44 million. The enterprise value is $71.31 million.

Market Cap	23.44M
Enterprise Value	71.31M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BTAI has 40.74 million shares outstanding. The number of shares has increased by 24.19% in one year.

Current Share Class	40.74M
Shares Outstanding	40.74M
Shares Change (YoY)	+24.19%
Shares Change (QoQ)	+5.31%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	8.60%
Float	32.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.24
Forward PS	2.60
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.11

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	-104.62%
Revenue Per Employee	$30,757
Profits Per Employee	-$959,405
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.17% in the last 52 weeks. The beta is 0.29, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-85.17%
50-Day Moving Average	0.60
200-Day Moving Average	1.56
Relative Strength Index (RSI)	44.10
Average Volume (20 Days)	465,806

Short Selling Information

The latest short interest is 347,081, so 0.85% of the outstanding shares have been sold short.

Short Interest	347,081
Short Previous Month	576,411
Short % of Shares Out	0.85%
Short % of Float	1.06%
Short Ratio (days to cover)	0.93

Income Statement

In the last 12 months, BTAI had revenue of $2.28 million and -$71.00 million in losses. Loss per share was -$1.99.

Revenue	2.28M
Gross Profit	251,000
Operating Income	-74.22M
Pretax Income	-107.83M
Net Income	-71.00M
EBITDA	-73.91M
EBIT	-74.22M
Loss Per Share	-$1.99

Full Income Statement

Balance Sheet

The company has $56.27 million in cash and $103.62 million in debt, giving a net cash position of -$47.35 million or -$1.16 per share.

Cash & Cash Equivalents	56.27M
Total Debt	103.62M
Net Cash	-47.35M
Net Cash Per Share	-$1.16
Equity (Book Value)	-74.30M
Book Value Per Share	-1.84
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	11.03%
Operating Margin	-3,260.90%
Pretax Margin	-3,119.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,383.15%

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.19%
Shareholder Yield	-24.19%
Earnings Yield	-306.72%
FCF Yield	n/a

Analyst Forecast

The average price target for BTAI is $5.00, which is 769.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	769.11%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	139.31%
EPS Growth Forecast (5Y)	-48.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a